BUTEO, a single arm, two-stage, multi-centre, phase II clinical trial is now recruiting participants. The trial investigates the safety and activity of the use of BTT1023, a human monoclonal antibody …
UK PSC has a new Chief Investigator. Dr Gideon Hirschfield successfully bid for the NIHR Rare Disease funding and is now leading the study. He is based at the NIHR …
We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly.I Understand